PIK3CA and breast carcinoma: Also important is that mutation of any PI3K residues are uncommon in human BLBCs according to TCGA and METABRIC sequencing analyses.18 In contrast, somatic PI3K activating mutations are commonly seen in human luminal breast cancers, indicating a strong cell type selectivity, though the underlying reason for this difference remains to be elucidated.